Research Article
Diagnostic Value of Serum Markers Combined with TVCDS in Ovarian Cancer Patients Treated with Bushen Yiqi Quyu Prescription
Table 4
Comparison of ultrasonographic features of TVCDS in OC patients before and after treatment between the two groups.
| Ultrasonographic features | Observation group | Control group | X2 | | Before treatment (n = 116) | After treatment (n = 78) | Before treatment (n = 116) | After treatment (n = 95) |
| Location | Above the middle | 74 | 52 | 69 | 57 | 1.347 | >0.05 | Below | 42 | 26 | 47 | 38 | Echo | Hypoechoic | 87 | 31 | 85 | 52 | 33.288 | <0.05 | High or equal echo | 29 | 47 | 31 | 43 | Boundary | Clarity | 79 | 55 | 82 | 74 | 2.642 | >0.05 | Obscure | 37 | 23 | 34 | 21 | Characters | Solid | 47 | 16 | 44 | 27 | 40.247 | <0.05 | Cyst-solid | 42 | 13 | 43 | 29 | Cystic | 27 | 49 | 29 | 39 | Shape | Round or oval | 49 | 23 | 53 | 37 | 5.443 | <0.05 | Irregular | 67 | 55 | 63 | 58 | Calcification | No | 12 | 25 | 15 | 23 | 54.532 | <0.05 | Tiny | 38 | 43 | 40 | 46 | Bulky | 66 | 10 | 61 | 26 | Internal blood flow | Not rich | 41 | 53 | 44 | 51 | 25.605 | <0.05 | Rich | 75 | 25 | 72 | 44 | Lymph node metastasis | No | 51 | 66 | 53 | 60 | 39.780 | <0.05 | Yes | 65 | 12 | 63 | 35 |
|
|